Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 4

Results For "pediatric"

274 News Found

Experts call for precision diagnosis and standardised neonatal protocols
Hospitals | April 15, 2026

Experts call for precision diagnosis and standardised neonatal protocols

The perinatology CME at Navi Mumbai brought together more than 100 obstetricians, pediatricians, and neonatologists


Dr Jitendra Singh stresses strong clinical foundations in medical education amid AI expansion
Healthcare | April 15, 2026

Dr Jitendra Singh stresses strong clinical foundations in medical education amid AI expansion

At launch of updated pediatric gastroenterology textbook, Union Minister says technology must strengthen not substitute core medical learning


Happiest Health expands dental care footprint with its second Happiest Pearls Clinic
Healthcare | April 14, 2026

Happiest Health expands dental care footprint with its second Happiest Pearls Clinic

Spread across nearly 4,500 sq. ft., the new clinic combines advanced dental technology, experienced specialists, and an Atithi-first care model


Glycomine completes enrollment in Phase 2b trial for rare genetic disorder
Clinical Trials | April 10, 2026

Glycomine completes enrollment in Phase 2b trial for rare genetic disorder

The study is a global, randomized, double-blind, placebo-controlled trial testing GLM101 for phosphomannomutase 2 congenital disorder of glycosylation


Danone India sets record with 20,911 healthcare pledges to fight anemia
Healthcare | April 05, 2026

Danone India sets record with 20,911 healthcare pledges to fight anemia

The record-setting effort stems from Danone India’s nationwide ‘IRON UP!’ campaign


Lupin receives FDA’s tentative approval for Sugammadex injection
Drug Approval | March 31, 2026

Lupin receives FDA’s tentative approval for Sugammadex injection

Sugammadex injection is bioequivalent to Merck’s Bridion injection for the reversal of neuromuscular blockade induced by rocuronium bromide and vecuronium bromide in adults and pediatric patients aged 2 years and older undergoing surgery


Bristol Myers Squibb’s Camzyos shows breakthrough results in adolescents with obstructive hypertrophic cardiomyopathy
Clinical Trials | March 31, 2026

Bristol Myers Squibb’s Camzyos shows breakthrough results in adolescents with obstructive hypertrophic cardiomyopathy

The SCOUT-HCM trial hit its primary endpoint, showing a clinically meaningful and statistically significant reduction in Valsalva left ventricular outflow tract


Novartis acquires Excellergy to bolster allergy portfolio
News | March 28, 2026

Novartis acquires Excellergy to bolster allergy portfolio

The move leverages Novartis’ deep expertise in IgE biology and long-standing presence in allergic disease treatments


FDA nod to Johnson & Johnson’s oral psoriasis therapy 'ICOTYDE'
News | March 25, 2026

FDA nod to Johnson & Johnson’s oral psoriasis therapy 'ICOTYDE'

New targeted pill offers hope for adults and teens with moderate-to-severe plaque psoriasis


Bayer wins world-first nod in Japan for low-dose MRI contrast agent
News | March 24, 2026

Bayer wins world-first nod in Japan for low-dose MRI contrast agent

Call it a major breakthrough for diagnostic imaging